Sanna Rijpma: The Evaluation of The Thrombin Generation Capacity in Detecting Coagulation Factor Deficiency
Sanna Rijpma, Clinical Chemist at Laboratory of Thrombosis and Hemostasis at Radboudumc, shared JTH‘s post on LinkedIn about a recent article she and her colleges co-authored:
“We have evaluated the capacity of thrombin generation in detecting coagulation factor deficiency; in my opinion essential for determining its place in the diagnostic trajectory.”
Quoting Journal of Thrombosis and Haemostasis (JTH)‘s post:
“Thrombin generation profiling in rare coagulation factor deficiencies: associations with bleeding severity and potential for screening
Thrombin generation profiling demonstrates superior diagnostic sensitivity compared to conventional coagulation screening, correlating strongly with bleeding severity in rare coagulation factor deficiencies and offering enhanced clinical evaluation capabilities.”
Title: Thrombin generation profiling in rare coagulation factor deficiencies: associations with bleeding severity and potential for screening
Authors: Bauke Haisma, Sanna R. Rijpma, Marjon H. Cnossen, Paul L. den Exter, Ilmar C. Kruis, Karina Meijer, Laurens Nieuwenhuizen, Nick van Es, Joline L. Saes, Nicole M.A. Blijlevens, Waander L. van Heerde, Saskia E.M. Schols
Read the Full Article in JTH.
Stay updated with Hemostasis Today.
-
Mar 3, 2026, 15:28Mary Cushman Elected ISTH President for 2028–2030
-
Mar 3, 2026, 15:20Brian A Beh: 5 Strategies to Assist and Maintain Motivation During Stroke Rehabilitation
-
Mar 3, 2026, 15:16Transplant vs CAR T Cells in Multiple Myeloma Debate at ESHMM 2026 – ESH
-
Mar 3, 2026, 15:07Nancy Di Salvo: Turning Challenges Into Purpose and Making Every Voice Count on Rare Disease Day 2026
-
Mar 3, 2026, 15:01Wolfgang Miesbach: How Laboratory Strategies Must Evolve to Meet Expanding Haemophilia Therapies
-
Mar 3, 2026, 14:46Jessica Nolan: Exploring Religious Coping in Stroke Survivors
-
Mar 3, 2026, 14:45Research Isn’t Abstract Science But a Pathway to Answers, Treatments, and Hope – ASH
-
Mar 3, 2026, 14:42Mervyn Morgan: Attending the Rare Haematology and Blood Disorders Cohort Meeting
-
Mar 3, 2026, 14:36Elsayed S. Moubarak: Evaluating Established and Emerging Biomarkers in Hemophilia A and B Management